
Sign up to save your podcasts
Or


Jef Akst, managing editor at BioSpace, talks about the major CGT issues she's been covering at #ASGCT2024 including regulatory considerations and AAV manufacturing. She also tells host Lynnea Olivarez what she hopes to be reporting on next year at the ASGCT Annual Meeting in New Orleans!
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.
By American Society of Gene & Cell Therapy4.9
1616 ratings
Jef Akst, managing editor at BioSpace, talks about the major CGT issues she's been covering at #ASGCT2024 including regulatory considerations and AAV manufacturing. She also tells host Lynnea Olivarez what she hopes to be reporting on next year at the ASGCT Annual Meeting in New Orleans!
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.

21,957 Listeners

25,874 Listeners

2,057 Listeners

499 Listeners

763 Listeners

820 Listeners

6,379 Listeners

277 Listeners

9,529 Listeners

324 Listeners

6,424 Listeners

34 Listeners

16,095 Listeners

19 Listeners

39 Listeners